Related Experiment Videos
Measles immunization: remaining needs for research
Abstract:
Highly immunogenic, safe, and effective attenuated measles vaccines, stabilized to lengthen duration of potency under field conditions, are available. Measles can be controlled while studies continue to define the molecular change in the viral genome responsible for attenuation and to clone the genes that specify for the two major surface glycoprotein antigens, the hemagglutinin (HA) and fusion (F) proteins. Purification of HA and F antigens will facilitate studies of cell-mediated immunity. Elucidation of host cell-dependent lack of synthesis of the internal membrane protein in the brains of patients with subacute sclerosing panencephalitis (SSPE) is needed. Control of measles will clarify the relationship between acute measles and those chronic neurologic diseases known (e.g., SSPE) or thought (e.g., multiple sclerosis) to be caused by persistent infection with measles virus. Epidemiologic studies should determine the optimal age for immunization as age-specific morbidity and mortality are reduced and should record the subsequent course of apparent vaccine failures in children immunized from seven to 15 months of age. Behavioral and operational research must examine how best to extend measles immunization throughout the world.
Insights
Highly effective measles vaccines are available for disease control. Ongoing research aims to understand viral attenuation, improve vaccine potency, and investigate links between measles and neurological conditions like SSPE.
Area of Science:
- Virology
- Immunology
- Epidemiology
Background:
- Measles vaccines are highly immunogenic, safe, and effective, with improved stability for field conditions.
- Measles control is achievable, but further research is needed on viral attenuation mechanisms.
Purpose of the Study:
- To define the molecular basis of measles virus attenuation.
- To clone genes encoding hemagglutinin (HA) and fusion (F) surface proteins for further study.
- To investigate the relationship between measles and chronic neurological diseases, such as subacute sclerosing panencephalitis (SSPE).
Main Methods:
- Ongoing studies to define molecular changes in the viral genome responsible for attenuation.
- Gene cloning for measles virus HA and F antigens.
- Epidemiologic studies to determine optimal immunization age and analyze vaccine failures.
- Research into host cell-dependent protein synthesis in SSPE.
Main Results:
- Availability of stabilized, effective attenuated measles vaccines.
- Progress in understanding viral attenuation and identifying key viral proteins (HA and F).
- Need for further research into measles' role in chronic neurological diseases.
Conclusions:
- Measles can be controlled with existing vaccines.
- Further research is crucial for understanding viral attenuation, improving vaccines, and clarifying links to neurological disorders.
- Optimizing immunization strategies and global vaccine access are essential for eradication.